Literature DB >> 15523499

Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans.

Inna Belfer1, Beata Buzas, Catherine Evans, Heather Hipp, Gabriel Phillips, Julie Taubman, Ilona Lorincz, Robert H Lipsky, Mary-Anne Enoch, Mitchell B Max, David Goldman.   

Abstract

The beta-adrenergic receptors (beta-AR) are G protein-coupled receptors activated by epinephrine and norepinephrine and are involved in a variety of their physiological functions. Previously, three beta-AR genes (ADRB1, ADRB2 and ADRB3) were resequenced, identifying polymorphisms that were used in genetic association studies of cardiovascular and metabolic disorders. These studies have produced intriguing but inconsistent results, potentially because the known functional variants: ADRB1 Arg389Gly and Gly49Ser, ADRB2 Arg16Gly and Gln27Glu, and ADRB3 Arg64Trp provided an incomplete picture of the total functional diversity at these genes. Therefore, we created marker panels for each beta-AR gene that included the known functional markers and also other markers evenly spaced and with sufficient density to identify haplotype block structure and to maximize haplotype diversity. A total of 27 markers were genotyped in 96 US Caucasians and 96 African Americans. In both populations and for each gene, a single block with little evidence of historical recombination was observed. For each gene, haplotype captured most of the information content of each functional locus, even if that locus was not genotyped, and presumably haplotype would capture the signal from unknown functional loci whose alleles are of moderate abundance. This study demonstrates the utility of using beta-AR gene haplotype maps and marker panels as tools for linkage studies on beta-AR function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15523499     DOI: 10.1038/sj.ejhg.5201313

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Authors:  Yasuhiko Igawa; Tim Schneider; Yoshinobu Yamazaki; Satoshi Tatemichi; Yukio Homma; Osamu Nishizawa; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-29       Impact factor: 3.000

2.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

Authors:  Gregory A Hawkins; Kelan Tantisira; Deborah A Meyers; Elizabeth J Ampleford; Wendy C Moore; Barbara Klanderman; Stephen B Liggett; Stephen P Peters; Scott T Weiss; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

Review 3.  The pharmacogenetics and pharmacogenomics of asthma therapy.

Authors:  S M Tse; K Tantisira; S T Weiss
Journal:  Pharmacogenomics J       Date:  2011-10-11       Impact factor: 3.550

4.  A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

Authors:  Babar Parvez; Nagesh Chopra; Shane Rowan; Joseph C Vaglio; Raafia Muhammad; Dan M Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

5.  Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.

Authors:  Luda Diatchenko; Amy D Anderson; Gary D Slade; Roger B Fillingim; Svetlana A Shabalina; Tomas J Higgins; Swetha Sama; Inna Belfer; David Goldman; Mitchell B Max; Bruce S Weir; William Maixner
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

6.  Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease.

Authors:  Zian H Tseng; Bradley E Aouizerat; Ludmila Pawlikowska; Eric Vittinghoff; Feng Lin; Dean Whiteman; Annie Poon; David Herrington; Timothy D Howard; Paul D Varosy; Stephen B Hulley; Mary Malloy; John Kane; Pui-Yan Kwok; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2008-03-14       Impact factor: 6.343

7.  Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Authors:  Daniel Kurnik; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mordechai Muszkat; Hong-Guang Xie; Paul A Harris; Scott M Williams; Usha B Nair; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

8.  Desensitization of beta-adrenergic receptors in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog.

Authors:  Syeda M Kabir; Shyamali Mukherjee; Veera Rajaratnam; Milton G Smith; Salil K Das
Journal:  J Biochem Mol Toxicol       Date:  2009 Jan-Feb       Impact factor: 3.642

9.  Progress toward personalized medicine for glaucoma.

Authors:  Sayoko E Moroi; Duna A Raoof; David M Reed; Sebastian Zöllner; Zhaohui Qin; Julia E Richards
Journal:  Expert Rev Ophthalmol       Date:  2009-04

10.  Race contributes to beta-blocker efficacy in pediatric patients with arrhythmias.

Authors:  BreAnn Taylor; Brady S Moffett; Michele Krenek; Santiago O Valdes; Jeffrey Kim
Journal:  Pediatr Cardiol       Date:  2013-11-19       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.